Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 15, 2006
Neovascularization: the Achilles' heel of tumors?
E E Voest
Anti-Cancer Drugs
|
September 1, 1996
Inhibitors of angiogenesis in a clinical perspective
E E Voest
Seminars in Oncology
|
March 20, 2001
The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer
M Los, E E Voest
Cell
|
March 29, 2024
Generating and using real-world data: A worthwhile uphill battle
K Verkerk, E E Voest
ESMO Open
|
March 20, 2025
Authors response to Letter re: The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP) molecular complexity and response to targeted therapy
K Verkerk, E E Voest
The Cancer Journal From Scientific American
|
May 1, 1997
Microvessel density and outcome of adjuvant treatment of breast cancer patients
E E Voest, G H Blijham
Molecular and Cellular Endocrinology
|
November 15, 2002
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches
R J A van Moorselaar, E E Voest
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 2000
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer
A Reijerkerk, E E Voest, M F Gebbink
European Journal of Clinical Investigation
|
September 1, 1999
New strategies in anti-vascular cancer therapy
H J Bloemendal, T Logtenberg, E E Voest
Annals of Internal Medicine
|
March 15, 1994
Iron-chelating agents in non-iron overload conditions
E E Voest, G Vreugdenhil, J J Marx
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 15, 2006
Neovascularization: the Achilles' heel of tumors?
E E Voest
Anti-Cancer Drugs
|
September 1, 1996
Inhibitors of angiogenesis in a clinical perspective
E E Voest
Seminars in Oncology
|
March 20, 2001
The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer
M Los, E E Voest
Cell
|
March 29, 2024
Generating and using real-world data: A worthwhile uphill battle
K Verkerk, E E Voest
ESMO Open
|
March 20, 2025
Authors response to Letter re: The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP) molecular complexity and response to targeted therapy
K Verkerk, E E Voest
The Cancer Journal From Scientific American
|
May 1, 1997
Microvessel density and outcome of adjuvant treatment of breast cancer patients
E E Voest, G H Blijham
Molecular and Cellular Endocrinology
|
November 15, 2002
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches
R J A van Moorselaar, E E Voest
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 2000
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer
A Reijerkerk, E E Voest, M F Gebbink
European Journal of Clinical Investigation
|
September 1, 1999
New strategies in anti-vascular cancer therapy
H J Bloemendal, T Logtenberg, E E Voest
Annals of Internal Medicine
|
March 15, 1994
Iron-chelating agents in non-iron overload conditions
E E Voest, G Vreugdenhil, J J Marx
Page
of 11